TVA-Recherche.be

TVA-Recherche à


Toutes les informations sur:

                        
Nom

Ophthalmology Innovations LTD.

Adresse
Lumaneri House Blythe Gate
Blythe Valley Park
Solihull
B90 8AH
VAT ID (Numéro de TVA) no VAT ID available
Société Numéro de Registre 07897544 Show on Companies House
Accountsmicro-entity
last accounts made up to 31 janvier 2022
Activité (Code NAF)86220 - Activité des médecins spécialistes
Statut de Sociétéactive
Noms Précédents
  • Opthalmology Innovations LTD
  • KYC Check
    KYC / PEP / AML request
    This data is incorrect?
    Source: Company Register: Companies House (companieshouse.gov.uk)

    Quick access

    Persons with Significant Control (2)

    Source: Companies House
    Raghavendran, Renuga Ramesh Status: Active Notified: 06/04/2016 Date of Birth: 04/1973 Nature of Control
  • Ownership of shares – More than 25% but not more than 50%
  • Sivaraj, Ramesh Raghavendran Status: Active Notified: 16/07/2019 Date of Birth: 11/1970 Nature of Control
  • Ownership of shares – More than 25% but not more than 50%
  • Officers (3)

    Source: Companies House
    Raghavendran, Renuga Ramesh Solihull, West Midlands, United Kingdom Status: Active Notified: 04/01/2012 Date of Birth: 04/1973 Occupation: Doctor Role: Director Country of Residence: United Kingdom Nationality: British
    Sivaraj, Ramesh Raghavendran Solihull, West Midlands, United Kingdom Status: Active Notified: 04/01/2012 Date of Birth: 11/1970 Occupation: Doctor Role: Director Country of Residence: England Nationality: English
    Raghavendran, Renuga Ramesh, Dr Solihull, United Kingdom Status: Ceased Notified: 04/01/2012 Ceased: 07/09/2023 Occupation: Doctor Role: Director Country of Residence: England Nationality: English

    Companies Controlled by This Company (1)

    gb-flag GB EYE-Docs Holdings Limited Status: Ceased Notified: 21/12/2021 Ceased: 21/12/2021 Companies House Number: 13736873 Nature of Control
  • Ownership of shares – More than 25% but not more than 50%
  • Ownership of voting rights - More than 25% but not more than 50%
  • Right to appoint and remove directors